13F HOLDINGS REPORT
Finepoint Capital LP
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0000904454-25-000119
Total Value
$1.64B
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 755,000 | $442.5M | 27.02% |
| 2 | QXO INC | QXO-PB | 24,933,825 | $396.4M | 24.21% |
| 3 | ISHARES TR | 464287655 | 1,485,000 | $328.1M | 20.04% |
| 4 | Liberty Broadband Corp | LBRDP | 2,015,710 | $150.7M | 9.20% |
| 5 | LIBERTY MEDIA CORP DEL | FWONB | 812,792 | $55.3M | 3.38% |
| 6 | Argenx SE | ARGX | 52,928 | $32.6M | 1.99% |
| 7 | REVOLUTION MEDICINES INC | RVMDW | 710,260 | $31.1M | 1.90% |
| 8 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 748,752 | $27.1M | 1.65% |
| 9 | ASCENDIS PHARMA A/S | ASND | 184,872 | $25.5M | 1.55% |
| 10 | MoonLake Immunotherapeutics | MLTX | 447,935 | $24.3M | 1.48% |
| 11 | SAREPTA THERAPEUTICS INC | SRPT | 161,935 | $19.7M | 1.20% |
| 12 | GALAPAGOS NV | GLPGF | 674,762 | $18.6M | 1.13% |
| 13 | XENCOR INC | XNCR | 660,000 | $15.2M | 0.93% |
| 14 | CYTOKINETICS INC | CYTK | 318,448 | $15.0M | 0.91% |
| 15 | ARVINAS INC | ARVN | 713,778 | $13.7M | 0.84% |
| 16 | AVIDITY BIOSCIENCES INC | 05370A108 | 391,300 | $11.4M | 0.69% |
| 17 | PROTHENA CORP PLC | PRTA | 657,071 | $9.1M | 0.56% |
| 18 | RELAY THERAPEUTICS INC | RLAY | 2,175,646 | $9.0M | 0.55% |
| 19 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,111,104 | $8.3M | 0.51% |
| 20 | SOLID BIOSCIENCES INC | SLDB | 961,251 | $3.8M | 0.23% |
| 21 | ALEANNA INC | ANNAW | 27,717 | $196,791 | 0.01% |
| 22 | ALEANNA INC | ANNAW | 490,000 | $68,600 | 0.00% |
| 23 | MONEYHERO LIMITED | MNYWW | 895,000 | $49,404 | 0.00% |
| 24 | LAKESHORE BIOPHARMA CO LTD | G9845F117 | 489,999 | $48,510 | 0.00% |
| 25 | Marblegate Acquisition Corp | 56608A113 | 735,000 | $25,652 | 0.00% |
| 26 | CALIDI BIOTHERAPEUTICS INC | CLDWW | 12,500 | $14,375 | 0.00% |